Gleason Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.19M | Buy |
9,418
+145
| +2% | +$19.1K | 0.1% | 44 |
|
|
2026
Q1 | $1.29M | Buy |
9,273
+56
| +0.6% | +$7.84K | 0.13% | 38 |
|
|
2025
Q4 | $1.13M | Buy |
9,217
+58
| +0.6% | +$7.05K | 0.11% | 42 |
|
|
2025
Q3 | $1.02M | Buy |
9,159
+64
| +0.7% | +$7.28K | 0.1% | 41 |
|
|
2025
Q2 | $1.01M | Buy |
9,095
+67
| +0.7% | +$7.13K | 0.11% | 40 |
|
|
2025
Q1 | $1.01M | Buy |
9,028
+64
| +0.7% | +$6.6K | 0.18% | 38 |
|
|
2024
Q4 | $828K | Buy |
8,964
+72
| +0.8% | +$6.48K | 0.15% | 41 |
|
|
2024
Q3 | $745K | Buy |
8,892
+5
| +0.1% | +$382 | 0.14% | 43 |
|
|
2024
Q2 | $610K | Buy |
8,887
+174
| +2% | +$11.6K | 0.12% | 46 |
|
|
2024
Q1 | $638K | Buy |
8,713
+91
| +1% | +$7K | 0.13% | 46 |
|
|
2023
Q4 | $698K | Buy |
8,622
+80
| +0.9% | +$6.22K | 0.16% | 45 |
|
|
2023
Q3 | $640K | Buy |
8,542
+84
| +1% | +$6.46K | 0.17% | 42 |
|
|
2023
Q2 | $652K | Buy |
8,458
+82
| +1% | +$6.54K | 0.17% | 45 |
|
|
2023
Q1 | $695K | Buy |
8,376
+77
| +0.9% | +$6.38K | 0.2% | 45 |
|
|
2022
Q4 | $712K | Buy |
8,299
+72
| +0.9% | +$5.7K | 0.22% | 42 |
|
|
2022
Q3 | $508K | Buy |
8,227
+93
| +1% | +$5.86K | 0.18% | 43 |
|
|
2022
Q2 | $503K | Buy |
8,134
+94
| +1% | +$5.82K | 0.17% | 45 |
|
|
2022
Q1 | $478K | Buy |
8,040
+97
| +1% | +$6.2K | 0.14% | 46 |
|
|
2021
Q4 | $577K | Buy |
7,943
+76
| +1% | +$5.24K | 0.19% | 43 |
|
|
2021
Q3 | $550K | Buy |
7,867
+79
| +1% | +$5.55K | 0.2% | 45 |
|
|
2021
Q2 | $536K | Buy |
7,788
+80
| +1% | +$5.34K | 0.19% | 45 |
|
|
2021
Q1 | $498K | Buy |
7,708
+2,083
| +37% | +$134K | 0.2% | 44 |
|
|
2020
Q4 | $328K | Buy |
5,625
+66
| +1% | +$3.98K | 0.16% | 50 |
|
|
2020
Q3 | $351K | Buy |
+5,559
| New | +$385K | 0.2% | 49 |
|
Other funds holding GILD
CIM
CNB
AP
P
QCM
KC